about
Stem cell treatment for acute myocardial infarctionHeparin versus placebo for non-ST elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesStem cell treatment for acute myocardial infarctionPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesMyeloid-related protein-8/14 is critical for the biological response to vascular injuryInhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding siteThe molecular mechanisms of the thrombotic complications of atherosclerosisAging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammationNoninvasive imaging modalities to visualize atherosclerotic plaquesBond-selective photoacoustic imaging by converting molecular vibration into acoustic waves.Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and managementNew Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque.Positron emission tomography imaging of atherosclerosisCoronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and managementElderly hypertensives: how are they different?Intravascular optical imaging technology for investigating the coronary arteryMR imaging of the coronary vasculature: imaging the lumen, wall, and beyondNon-invasive vulnerable plaque imaging: how do we know that treatment works?Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle CellsCardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart DiseaseUltrasound imaging for risk assessment in atherosclerosis.Antiplatelet therapy in cardiovascular diseaseIncreased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarctionNovel determinants of plaque instabilityPlatelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarctionOpportunities for the treatment of inflammation in cardiovascular diseaseEndothelial dysfunction: a comprehensive appraisal.Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problemsRaised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndromeThrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor compositionCathepsin G activity lowers plasma LDL and reduces atherosclerosisDirect effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout miceEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsCarotid plaque age is a feature of plaque stability inversely related to levels of plasma insulinA genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in JapanesePlaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events.
P2860
Q24186920-DB705294-527F-471F-8F66-86CA20ED61B5Q24193744-79883783-AFBD-4AC6-86BD-D528054E659EQ24202522-6BB1078A-DACC-482A-B0D6-25DE4EE1E5D8Q24202999-ECAAD4A4-FF2D-4513-8A12-2DFA41252C56Q24203736-E8F6A841-AB5A-49F2-BB59-465C71392457Q24235385-4A96C6D5-65AF-4054-95F3-363D8D7E03D5Q24627504-C758A92B-39C0-46E8-B47E-41AE9A4A004AQ24627747-20C600DD-D51C-4170-A6D5-51144C8FB561Q24656816-A556A83A-DDD1-47A8-BCF2-CA865EF1A708Q24797866-23667936-FDC2-4F35-87B8-8EE70531F2D4Q26738579-FEA04018-C302-4D9C-9530-D9A527726452Q26748979-A5ADEA9C-FE46-42FF-AFC0-6D059506F052Q26751001-E5A531E0-D9DD-4FDF-A2FE-D1DCD77E765CQ26765488-5C52D808-8F23-423E-A48C-20CA84C4A115Q26769824-6FA67D21-B67B-41D0-AE97-E92C98FE8B52Q26824610-6A9EF95A-090F-4517-917F-3348DEFBB823Q26830317-B3EC567E-3AD8-4690-9AEA-F034C9B17A97Q26830725-7052F2E1-D7BE-4F14-92FC-44DD9C27EE70Q26852822-99AC9FA7-4C7C-4635-9DB3-68E44A874AB3Q26991944-631FEA79-D27F-4119-BDD1-1FC08C97F8FFQ27020959-3424F9C1-C40F-466F-85F6-53BC2F6758DBQ27315813-D8EBDBD1-30A4-485A-B5F1-0DA9774A95D9Q27687888-2A6B6773-5BFC-44B0-9A3B-2787E7174DE6Q28066080-37465D94-A173-438C-B6E5-9355F4785E33Q28087550-9F5B7B3C-9083-4E81-8CD7-EC1638BF1266Q28167737-EB7DFB6A-BC67-4F5B-AAAA-6BD74DABF58DQ28168338-8235227B-0359-4387-87F2-E4B9F1BF5A8FQ28187632-DCBF50A1-9DBA-43B0-AA33-0C14A0F84DB3Q28191096-6EABDC4A-9427-4DD0-917A-162CC3E5301BQ28192292-32C87BA9-7CF8-447B-B46C-36806B145216Q28195411-CF842F6C-DD85-4336-9EE6-2E243BE2A54BQ28218351-FE886DA6-4232-40B5-84AE-9473739C835CQ28219323-9A8DB43E-B127-4033-A874-99BA669EB889Q28222922-130F9F00-F6C3-4C9F-9E06-9ADBFA4497D2Q28245234-21FCC82D-0E06-475E-983B-4210A63E9E51Q28345443-07CB5C70-A82B-4A40-A1FE-DD55E42CD178Q28730724-9D0B0BDE-C705-4212-BA32-6316278DF374Q28741327-DE651455-97C4-4666-834D-E5AB7B8F9DC4Q28943469-11A3ADAF-7679-4485-94A8-6524B7E50742Q30275428-FC127BF4-40E8-434E-906A-0867DDC3D441
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Coronary plaque disruption.
@en
type
label
Coronary plaque disruption.
@en
prefLabel
Coronary plaque disruption.
@en
P2093
P356
P1433
P1476
Coronary plaque disruption.
@en
P2093
P304
P356
10.1161/01.CIR.92.3.657
P407
P577
1995-08-01T00:00:00Z